Emergent BioSolutions (NYSE: EBS) announced that, under several agreements signed with the University of Oxford, GlaxoSmithKline (NYSE: GSK), and the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE